Vistagen Therapeutics, Inc. (VTGN) AI Dilution Summary

Vistagen reported cash of $31,730,000 at 2026-06-30 against estimated monthly burn of $4,902,333. Its funding channel is an active at-the-market program with Jefferies LLC, authorised to $175,000,000. That ATM program is the main driver of dilution, with $139,500,000 of remaining capacity.